HLA-DPA1 and carcinoma: A very recent single cell RNA sequencing study reported that malignant epithelial cells from an EBVaGC expressed higher levels of both HLA-DPA1 and HLA-DPB1 compared to the other GCs studied, definitively showing that these mRNAs originate from carcinoma cells, rather than professional APCs within the tumor47.